Bilirubin-induced neurologic dysfunction (BIND) and kernicterus has been used to describe moderate to severe neurological dysfunction observed in children exposed to excessive levels of total serum bilirubin (TCB) during the neonatal period. Here we use a new mouse model that targets deletion of the Ugt1 locus and the Ugt1a1 gene in liver to promote hyperbilirubinemia induced seizures and CNS toxicity. The accumulation of TCB in these mice leads to diffuse yellow coloration of brain tissue and a marked cerebellar hypoplasia that we characterize as kernicterus. Histological studies of brain tissue demonstrate that the onset of severe neonatal hyperbilirubinemia, characterized by seizures, leads to alterations in myelination and glia reactivity. Kernicterus presents axonopathy with myelination deficits at different brain regions including pons, medulla oblongata and cerebellum. The excessive accumulation of TSB in the early neonatal period (5-days after birth) promotes activation of the myelin basic protein (Mbp) gene with an accelerated loss of MBP that correlates with a lack of myelin sheath formation.
These changes were accompanied by increased astroglial and microglial reactivity, possibly as a response to myelination injury. Interestingly, cerebellum was the most affected area with greater myelination impairment and glia burden, showing a marked loss of Purkinje cells and a reduced arborization of the remaining ones. Thus, kernicterus in this model displays not only axonal damage but also myelination deficits and glial activation in different brain regions that are usually related to the neurological sequelae observed after severe hyperbilirubinemia.
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Introduction
Hyperbilirubinemia is a common clinical condition occurring in the neonatal period. Over 60% of term and virtually all premature infants experience temporary, mild to moderate "physiological" jaundice, due to excessive production of unconjugated bilirubin (UCB) and defective bilirubin clearance (Stevenson et al., 2001; Cohen et al., 2010) . In the vast majority of cases neonatal jaundice represents a benign condition, but in some newborns the concentration of serum bilirubin may increase with passage of the pigment into brain causing various degrees of acute or chronic bilirubin induced neurological dysfunction (BIND) which can expand to UCB-induced encephalopathy (kernicterus) (Shapiro, 2003; Shapiro, 2005; Shapiro, 2010) . In this situation bilirubin leads to cellular neuroinflammation with activation of astrocytes and microglia, as well as gliosis. (Shapiro, 2005; Yueh et al., 2014; Johnson and Bhutani, 2011; Brites, 2012) .
The bench mark of extreme bilirubin neurotoxicity or kernicterus is an irreversible posticteric sequelae, presented as icteric or yellow staining of brain tissue resulting from the accumulation of UCB in selective regions of the brain (Johnson and .
Hence, it is important to understand the molecular mechanisms by which bilirubin exerts such neurodevelopmental abnormalities.
Humanized UGT1 (hUGT1) mice express the human UGT1 locus in a Ugt1-null background (Fujiwara et al., 2010) . Mutation of the Ugt1 locus by interruption of exon 4 in the common region of the Ugt1a1 gene leads to inactivation of the UGT1A proteins, including UGT1A1 (Nguyen et al., 2008) . Since UGT1A1 is the only glucuronosyltransferase responsible for the glucuronidation of bilirubin (Bosma et al., 1994) , Ugt1 -/mice accumulate high levels of UCB, resulting in neonatal lethality approximately one week after birth. Incorporating the human UGT1 locus through transgenic technology into the Ugt1-null background leads to recovery of neonatal (Fujiwara et al., 2010) . Approximately 10% of neonatal hUGT1 mice progress into seizures, succumbing to CNS toxicity as evident by accumulation of bilirubin in brain tissue. The stark accumulation of bilirubin in brain tissue coincides with neuroinflammation and reactive gliosis, a term we have defined as "kernicterus" in these mice, which we have also found linked to Toll-like receptor 2 (TLR2) control of bilirubin induced signaling (Yueh et al., 2014) . TRL2 mediated gliosis correlated with the development of a bilirubin induced pro-inflammatory environment with upregulation of inflammatory markers such as TNFα, IL-1β and IL-6 in the CNS.
Expression of TRL2 is a key intermediate in regulating the onset of BIND, since deleting the Tlr2 gene in hUGT1 mice leads to a dramatic increase in the neonatal death rate in hUGT1/Trl2 -/mice. These findings represent the first mechanistic link between hyperbilirubinemia and the CNS toxicity, demonstrating that TLR2 signaling and microglia-associated neuroinflammation are linked to a repair and protection mode against BIND.
The early onset of hyperbilirubinemia during the neonatal period in hUGT1 mice is identified by severely elevated levels of total serum bilirubin (TSB) that coinside with the onset of seizures. While approximately 1 in 10 hUGT1 mice develop these symptoms (Fujiwara et al., 2010) , we sought to develop a more consistent mouse model to examine the impact of hyperbilirubinemia on gliosis and CNS damage. This was accomplished by using the Cre/loxP system (Lewandoski, 2001) Immunoblotting: Liver (MLM) and small intestinal microsomes (MSIM) from mice were prepared as previously described (Chen et al., 2013) . All Western blots were performed by using NuPAGE 4-12% BisTris-polyacrylamide gels as outlined by the supplier (Invitrogen). Following transfer of the proteins, membranes were blocked with 5% nonfat dry milk in Tris-buffered saline for 1 hour and then incubated with primary antibodies in Tris-buffered saline overnight. Membranes were washed and incubated with horseradish peroxidase-conjugated secondary antibody for 1 hour. Antibodies used were a rabbit anti-human UGT1A1 (Chen et al., 2013) and a mouse anti-bovine myelin basic protein (BioRad #MCA409S). Both antibodies cross reacted with the mouse proteins. The conjugated horseradish peroxidase was detected using the ECL plus Western blotting detection system (Amersham Biosciences) and visualized by the BioRad gel documentation system.
Bilirubin glucuronidation assays:
Bilirubin glucuronidation activity assay was performed as described previously (Chen et al., 2013) . In brief, MLM or MSIM were incubated with different concentrations of bilirubin in reaction buffer containing 2 mM UDP-glucuronic acid (UDPGA). All reactions were performed in the dark. Bilirubin diglucuronide formation was determined by liquid chromatography Alliance 2695 (Waters, MA) coupled to tandem mass spectrometry (API 4000 Applied Biosystems, Canada 
Measuring myelination and counting Iba1-and GFAP-labeled cells:
In order to evaluate if kernicterus mice present alterations in brain morphology, axonal viability and myelination along several brain regions, sections were stained with neurofilament and MBP. To evaluate overall neuronal and myelination alterations, 10x magnification images were acquired and stitched using Microsoft image composite editor. Then binary masks were specified in ImgeJ software using the same cut-off intensity threshold value for each region of interest, defined as the minimum intensity due to specific staining above background values. Finally, the percentage of area immunoreactive for neurofilament and MBP was measured. In addition, it was also calculated the percentage of myelinated fibers obtained by the ratio of MBP to neurofilaments This article has not been copyedited and formatted. The final version may differ from this version. staining. Moreover, changes in brain morphology were identified measuring the percentage of brain area occupied by cerebellum using the same software.
To evaluate more closely changes in myelination in the different brain areas, the percentage of area immunoreactive for neurofilament and MBP was measured in 40x magnification images, using binary masks as described before, in different brain regions (medulla oblongata, pons, cerebellum and corpus callosum) and in specific regions of cerebellum (white matter ramifications, middle of white matter tracts and white matter terminals).
To evaluate microglia and astrocytes, we determined the number of cells with positive staining for Iba-1 and GFAP, respectively, in the same regions that we evaluated myelination alterations. All results were given by averaging values determined in at least seven separate microscopic fields from three different sections from two control animals and three Kernicterus animals. Values are expressed as mean ± SEM.
Statistical analysis
All results are presented as mean ± SEM. Significant differences between two groups were determined by the two-tailed t-test performed on the basis of equal and unequal variance as appropriate and the P-values of * p < 0.05 and ** p < 0.01 were considered as statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. 1F) . Hypomorphic gene expression is often seen following integration of targeting constructs through homologous recombination (Lewandoski, 2001) . In UFP mice, hypomorphic expression of the Ugt1a1 gene is not lethal, with neonatal and adult mice displaying elevated TSB levels. Hypomorphic
Ugt1a1 gene expression in liver tissue from UFP mice confirmed a reduction in mature RNA transcripts ( Fig 1B) , which corresponded to a reduced UGT1A1 protein expression ( Fig 1C) and bilirubin UGT activity ( Fig 1D) . Reduced Ugt1a1 gene expression occurs in all tissues in UFP mice, with an example being displayed in small UFP/albumin-Cre mice, which are termed UAC mice ( Fig 1A) . Expression of Crerecombinase from the albumin-Cre transgene leads to the deletion of exons 3 and 4 in the liver tissue only of the Ugt1a1 gene. Liver tissue from UAC mice at 14 days after birth have no mature UGT1A1 RNA ( Fig 1B) or microsomal UGT1A1 protein as determined by Western blot analysis ( Fig 1C) , and no measureable bilirubin UGT activity ( Fig 1D) . Newborn UAC mice show high levels of TSB ( Fig 1F) that peak around 14 days after birth. The elevated TSB levels in UAC mice eventually leads to a 95% lethality rate ( Fig 1E) . The neonatal UAC mice show visible signs of CNS toxicity prior to death, as evident from the appearance of tremors and seizures.
Alterations in brain morphology of kernicterus mice. When brains were isolated from 14-day old UAC mice a diffuse yellow staining (kernicterus) throughout the brain was apparent (Fig. 1G) . When compared to UFP mice, which do not accumulate bilirubin in brain tissue, UAC mice had a reduced cerebellar volume, as previously shown in humanized UGT1 mice (Fujiwara et al., 2010) as well as in the Gunn rat model (Conlee and Shapiro, 1997) . When saggital brain sections were immunostained ( Figure 2) , marked reduction of the cerebellum was observed in UAC mice when compared with the UFP littermates. Haematoxylin Eosin (H&E) and Cresyl Violet (Nissl) staining were used to quantitate cerebellum size in UFP and UAC mice (Supplement 2). Interestingly, the global brain area is not affected, possibly due to an increased dimension of the cortex and midbrain on top of the cerebellum.
Kernicterus mice present axonal loss and decreased myelination. Brain sections
were immunostained for neurofilaments and myelin basic protein (MBP) to calculate the percentage of brain area occupied by these markers. As depicted in Figure 2A , a This article has not been copyedited and formatted. The final version may differ from this version. To examine if the early onset of bilirubin toxicity in the cerebellum had an impact on myelin sheath formation, we examined the expression pattern of MBP at 5days after birth when TSB levels are already dramatically elevated ( Fig 2B) .
Immunocytochemistry analysis showed a reduction in myelination in newborn UAC mice when compared to healthy UFP mice. Real time PCR analysis has confirmed that expression of the Mbp gene in the cerebellum in UAC mice is significantly induced, possibly in response to the inflammatory insult initiated by elevated bilirubin levels.
Interestingly, accelerated gene expression is followed by a significant reduction in MBP accumulation as shown by Western blot analysis, which correlates with reduced myelin sheath formation.
Kernicterus mice present reduced myelination and increased glial reactivity in cerebellum, medulla oblongata and pons. As changes in myelination along different brain regions were observed, brain regions that presented myelination at postnatal day 7 were examined. Changes in myelination in medulla, pons, cerebellum and corpus callosum were evaluated, the last as a positive control of myelination since it is one of the first myelinated areas of the brain (Sturrock, 1980) . As depicted in Figure   This article has not been copyedited and formatted. The final version may differ from this version. 3A and 4A, there was a decrease in the percentage of myelinated fibers in medulla (0.81 ± 0.03, p<0.01), and a more marked effect in pons (0.58 ± 0.03, p<0.01) and cerebellum (0.61 ± 0.04, p<0.01), with no effect on corpus callosum (Supplement Fig 3) . Brain sections prepared from UFP mice show myelinated fibers that are long and thin, while in diseased UAC mice the MBP staining appears as fragmented fibers and myelin agglomerates, suggesting a destruction of the myelin sheath surrounding the axons.
Interestingly, the corpus callosum maintains the long myelinated fibers even in the kernicterus mice, corroborating the absence of myelin changes in that area. It is known that astrocytes (Zhang et al., 2006) and microglia (Olah et al., 2012) cooperate to create a favorable environment for myelination, while upon myelination injury they are rapidly activated (Petzold et al., 2002) . To examine if gliosis takes place in kernicterus brain, microglia and astrocyte reactivity were identified by Iba-1 and GFAP staining, respectively. As shown in Figure 3 , the kernicterus mice presented a marked increase in both microglia and astrocytes in cerebellum, medulla and pons with no effect in the corpus callosum ( Supplement Fig 3) . Regarding microglia ( Fig. 3B and 4B ), the major increase was observed in cerebellum (3.75-fold ± 0.04, p<0.01), followed by pons (2.22-fold ± 0.07, p<0.01) and medulla (1.68-fold ± 0.21, p<0.05). Concerning astrocytes, very similar increases were observed in medulla and cerebellum (3.73-fold ± 0.17, p<0.05 and 3.95-fold ± 0.08, p<0.01, respectively), but the most pronounced effects were noticed in pons (29.08-fold ± 3.93, p<0.01). Regarding the corpus callosum, this region with a considerable number of glial cells in the control animals showed no noticeable changes in the kernicterus mice.
Distinct white matter regions from cerebellum present different alterations in myelination and glial reactivity. Since cerebellum is one of the most affected areas
This article has not been copyedited and formatted. The final version may differ from this version. and it seems to present regional changes in myelination and glial reactivity, the cerebellum was divided into three distinct zones as depicted in Figure 5A ; the white matter nodes (region 1), the middle of the white matter tracts (region 2), and white matter terminals (region 3). When myelination was evaluated ( Fig. 5B and 6B) there was a marked decrease in the percentage of myelinated fibers in the kernicterus mice.
The major effects were observed at white matter terminals (0.45-fold ± 0.07, p<0.01), followed by central white matter tracts (0.58-fold ± 0.04, p<0.01) and finally, a less pronounced but significant alteration was observed in white matter nodes (0.72-fold ± 0.05, p<0.05).
When the number of glial cells in these regions were evaluated there was a marked increase in both astrocyte and microglia number in cerebellum white matter of kernicterus mice (Fig. 5C , D and 6 C, D). In this context, there was an increased number of microglia in all three regions with a similar pattern to what was observed for myelination. Indeed, the most affected area was the white matter terminals (5.37-fold ± 0.18, p<0.01), followed by central white matter tracts (5.05-fold ± 0.27, p<0.01) and white matter nodes (3.11 ± 0.17, p<0.01). On the other hand, when astrocyte number was evaluated, kernicterus mice presented a very similar increase in both white matter nodes and terminals (3.36-fold ± 0.18, p<0.01 and 3.31-fold ± 0.25, respectively, p<0.01), with the most affected area being the central white matter (4.28-fold ± 0.15, p<0.01).
It deserves to be noted that while white matter terminals were the most affected area pertaining to changes in myelination and microgliosis, the changes in astrogliosis were mainly observed in the middle of the white matter tracts, possibly suggesting a different role for microglia and astrocytes in response to UCB injury. Kernicterus mice present cerebellum atrophy and a great reduction in Purkinje cell number. Besides changes observed in myelination and glial reactivity, the cerebellum volume is greatly reduced in kernicterus animals, a feature also observed in Gunn rats that were traumatized by sulfadimethoxine administration to increase TSB levels (Conlee and Shapiro, 1997) . As depicted in Figures 2 and 7A , UAC mice present a marked derangement of cerebellar lobules resulting in a greater reduction in the area occupied by cerebellum when compared with total brain area (0.45-fold ± 0.03, p<0.01).
This cerebellum atrophy in kernicterus mice can be due to a massive reduction in the number of Purkinje cells (0.21-fold ± 0.03, p<0.01) mainly in the anterior lobes, and shrinkage of molecular and granular layers, as shown in Figure 7A . Purkinje cells that remained in the kernicterus brains ( Fig. 7A) presented an altered morphology with reduced number of branches suggesting that cerebellar neuronal circuitry may be markedly affected.
This article has not been copyedited and formatted. The final version may differ from this version. It has been demonstrated that UCB impairs oligodendrocyte differentiation and consequent myelination in vitro using dorsal-root ganglia-oligodendrocyte co-cultures (Barateiro et al., 2013) and ex vivo in organotypic cerebellar slice cultures (Barateiro et al., 2012) . These observations are consistent with previous reports showing a decrease in the density of myelinated fibers and a loss of axons in the cerebellum of a premature infant with kernicterus (Brito et al., 2012) , along with white matter volume reduction and delayed hemispheric myelination as observed in infants with severe UCB encephalopathy (Gkoltsiou et al., 2008) . In UAC mice, there was a marked impairment This article has not been copyedited and formatted. The final version may differ from this version. of myelination. Indeed, fragmentation of myelinated fibers within the cerebellum, medulla oblongata and pons was detected, a finding which indicated that toxic levels of bilirubin led to damage of the myelin sheath. Myelination deficits have also been reported in several other perinatal conditions, including moderate perinatal systemic inflammation (Favrais et al., 2011) , perinatal hypoxic-ischemia (Huang et al., 2009 ) and white matter injury in the premature baby (Buser et al., 2012) . Since it is known that neuronal-oligodendrocyte cross-talk is crucial for proper myelination (Lee and Fields, 2009), myelination impairment observed in the kernicterus mice may be due in part to a reduced number of viable axons limiting oligodendrocyte differentiation and myelination. Nevertheless, the percentage of myelination in the remaining fibers was also affected in these animals corroborating the toxic role of bilirubin on oligodendrocyte maturation, as previously seen in several in vitro models. Actually, as reported for white matter injury (Buser et al., 2012) , myelination failure may arise from the inability of oligodendrocyte precursors to generate myelinating oligodendrocytes in order to repair the injury.
It deserves to be noted that the increased astrogliosis and microgliosis in UAC mice overlay those brain areas that present myelin damage. This fact is more pronounced in the cerebellum (Fig. 4) , where recruitment of both microglia and astrocytes in the surrounding white matter is induced. It is known that upon myelination damage both astrocytes and microglia are rapidly activated and migrate to the site of injury (Petzold et al., 2002) with sustained astrocyte presence along myelination (Miron et al., 2010; Petzold et al., 2002) , even during the perinatal period (Buser et al., 2012; Huang et al., 2009) . Upon demyelination, microglia are responsible for clearing myelin debris to allow for proper re-myelination (Olah et al., 2012) . In addition, astrocytes and microglia produce growth factors that can facilitate oligodendrocyte This article has not been copyedited and formatted. The final version may differ from this version. survival, differentiation and the ability to myelinate (Zhang et al., 2006; Stankoff et al., 2002; Olah et al., 2012) , creating a favorable environment for repair. Indeed, we observed an acute increase in the number of microglia in the most affected areas of myelin deficits suggesting that these cells have been recruited to clear the damaged myelin. In the cerebellum where myelin sheath formation is inhibited, Mbp gene expression was significantly induced, possibly in response to the inflammatory insult in this brain region and the production of reactive oxygen species, or even as a compensatory response to the lack of functional MBP which has been degraded as a result of intense gliosis.
It can also be argued that if activated, microglia and astrocytes may release high amounts of proinflammatory mediators that are known toxicants for oligodendrocytes and their progenitors. This was observed in hUGT1 mice and hUGT1/Trl2 -/mice that seizure, and show distinct glial cell activation (Yueh et al., 2014) . It has been shown that activated microglia induced Purkinje neuronal death through TNF-α and IL-1β signaling (Kaur et al., 2013) . Thus, myelination impairment and loss of Purkinje cells in the UAC mice may be due to oligodendrocyte damage by glial-derived inflammatory factors. In addition, it has been reported that following white matter injury in the premature, astrogliosis extended into the site of injury causing inhibition of oligodendrocyte differentiation and consequent myelination as a result of hyaluronic acid production (Buser et al., 2012 Cerebellar hypoplasia was the more marked feature observed in the kernicterus mice, as also demonstrated with a similar Ugt1 -/mouse model (Bortolussi et al., 2015) .
In a single case of a preterm infant that was diagnosed with kernicterus, histological analysis revealed a loss of myelin fibers in the cerebellum (Brito et al., 2012) , indicating similarity with kernicterus in humans and our mouse model. Indeed, these findings revealed that increased circulating levels TSB derange cerebellar lobules, with a reduction of the thickness of the molecular and granular layers, and a marked loss of Purkinje cells that coincides with reduced branching of the remaining cells. Similar features were noted in Gunn rats (O'Callaghan and Miller, 1985; Conlee and Shapiro, 1997) . The rodent cerebellar lobules mature postnatally, increasing over 20-fold from birth to 21 postnatal days. Interestingly, the cells within the ventral lobes, namely
Purkinje cells, mature first followed by those in the anterior lobes (Altman, 1969) , and may be susceptible to toxic levels of bilirubin. In UAC mice there is an increased loss of Purkinje cells in the anterior lobe. This finding suggests that elevated bilirubin levels early in the neonatal stages drives toxicity towards those regions of the CNS that are underdeveloped. This fact may be corroborated by earlier findings showing that immature neurons and astrocytes are more susceptible to UCB toxicity and cell death than mature ones (Falcao et al., 2006) .
The cerebellum is a region of the brain that plays an important role in motor control, and contributes towards coordination, precision, and timing of movements (Fine et al., 2002) . Therefore, damage to the cerebellum, as observed in UAC mice, may justify the abnormal motor control, movements and muscle tone observed in these mice, as well as in hUGT1 mice (Fujiwara et al., 2010; Vogel et al., 2011) . Similar motor deficits were observed clinically in severe neonatal hyperbilirubinemia (Shapiro, 2010) .
Interestingly, in UAC mice we also show alterations in several brain regions that are M O L # 9 8 2 2 8 2 2
commonly affected in human neonatal brains that develop kernicterus (Bhutani and Stevenson, 2011) . Indeed, we have observed myelin deficits and gliosis in medulla oblongata and pons of kernicterus mice. Both medulla oblongata and pons are structures located on the brainstem, with the medulla being on the lower half of the brainstem, and the pons above the medulla yet below the midbrain and ventral to the cerebellum. The medulla oblongata connects the higher levels of the brain to the spinal cord and has an important role in the control of nervous system autonomic functions, including the reflex center of swallowing (Jean, 1984) . Interestingly, a history of past or present suckling and swallowing dysfunction is often described in children with kernicterus (Shapiro, 2010) , which may occur as a result of altered function of the medulla nerve cells as observed in our animal model.
Overall, our study reveals a new animal model of kernicterus showing anatomical and histological changes that may justify the clinical symptoms often detected in infants subjected to severe neonatal hyperbilirubinemia. Further studies will need to be conducted to examine the similarities and differences that occur in kernicterus syndrome from published reports in humans with those observed in our mouse model. However, we have identified deficits in myelination and enhanced gliosis in the kernicterus mice that are similar to findings in human brain sections, indicating that mechanisms responsible for the neurological dysfunction described in moderate to severe hyperbilirubinemia may be viewed as potential targets for new therapeutic strategies.
